Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open‐label, blinded‐endpoint, randomized controlled study (PRIME‐V study)

A prospective, multicentre, open‐label, blinded‐endpoint, randomized controlled study was conducted to evaluate the efficacy of treatment with ipragliflozin (sodium‐dependent glucose transporter‐2 inhibitor) versus metformin for visceral fat reduction and glycaemic control among Japanese patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Koshizaka, Masaya, Ishikawa, Ko, Ishibashi, Ryoichi, Maezawa, Yoshiro, Sakamoto, Kenichi, Uchida, Daigaku, Nakamura, Susumu, Yamaga, Masaya, Yokoh, Hidetaka, Kobayashi, Akina, Onishi, Shunichiro, Kobayashi, Kazuki, Ogino, Jun, Hashimoto, Naotake, Tokuyama, Hirotake, Shimada, Fumio, Ohara, Emi, Ishikawa, Takahiro, Shoji, Mayumi, Ide, Shintaro, Ide, Kana, Baba, Yusuke, Hattori, Akiko, Kitamoto, Takumi, Horikoshi, Takuro, Shimofusa, Ryota, Takahashi, Sho, Nagashima, Kengo, Sato, Yasunori, Takemoto, Minoru, Newby, Laura Kristin, Yokote, Koutaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2019
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767075/
https://www.ncbi.nlm.nih.gov/pubmed/30993861
http://dx.doi.org/10.1111/dom.13750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767075/
https://www.ncbi.nlm.nih.gov/pubmed/30993861
http://dx.doi.org/10.1111/dom.13750

Ejemplares similares